
Hashem Farrokh
Examiner (ID: 13119, Phone: (571)272-4193 , Office: P/2131 )
| Most Active Art Unit | 2138 |
| Art Unit(s) | 2188, 2187, 2138, 2131, 2135 |
| Total Applications | 1256 |
| Issued Applications | 1101 |
| Pending Applications | 60 |
| Abandoned Applications | 119 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17426856
[patent_doc_number] => 20220054564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => SENECA VALLEY VIRUS (SVV) CELLULAR RECEPTOR TARGETED ONCOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/406380
[patent_app_country] => US
[patent_app_date] => 2021-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15344
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17406380
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/406380 | Seneca valley virus (SVV) cellular receptor targeted oncotherapy | Aug 18, 2021 | Issued |
Array
(
[id] => 17542085
[patent_doc_number] => 11307202
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2022-04-19
[patent_title] => Antibody binding detection method for detecting MERS-CoV
[patent_app_type] => utility
[patent_app_number] => 17/406182
[patent_app_country] => US
[patent_app_date] => 2021-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11487
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17406182
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/406182 | Antibody binding detection method for detecting MERS-CoV | Aug 18, 2021 | Issued |
Array
(
[id] => 19778740
[patent_doc_number] => 12227764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Pepmixes to generate multiviral CTLs with broad specificity
[patent_app_type] => utility
[patent_app_number] => 17/443261
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 12703
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17443261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/443261 | Pepmixes to generate multiviral CTLs with broad specificity | Jul 22, 2021 | Issued |
Array
(
[id] => 18596052
[patent_doc_number] => 20230270843
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => Post-Exposure Vaccination Against Viral Respiratory Infections
[patent_app_type] => utility
[patent_app_number] => 18/005780
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005780
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/005780 | Post-Exposure Vaccination Against Viral Respiratory Infections | Jul 13, 2021 | Pending |
Array
(
[id] => 17201277
[patent_doc_number] => 20210341372
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => METHOD OF QUANTITATIVE MEASUREMENT OF PARTICLE CONTENT USING HYDRATED STATE IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/371143
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3505
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371143
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371143 | METHOD OF QUANTITATIVE MEASUREMENT OF PARTICLE CONTENT USING HYDRATED STATE IMAGING | Jul 8, 2021 | Abandoned |
Array
(
[id] => 19923189
[patent_doc_number] => 12297460
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-05-13
[patent_title] => Viral preparations and methods for treating and modulating mitochondrial effects of coronavirus infections
[patent_app_type] => utility
[patent_app_number] => 17/368994
[patent_app_country] => US
[patent_app_date] => 2021-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5033
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17368994
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/368994 | Viral preparations and methods for treating and modulating mitochondrial effects of coronavirus infections | Jul 6, 2021 | Issued |
Array
(
[id] => 18610919
[patent_doc_number] => 20230277649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => SWINE INFLUENZA A VIRUS VACCINE COMPRISING TWO DISTINCT RNA REPLICON PARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/010412
[patent_app_country] => US
[patent_app_date] => 2021-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18010412
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/010412 | SWINE INFLUENZA A VIRUS VACCINE COMPRISING TWO DISTINCT RNA REPLICON PARTICLES | Jun 17, 2021 | Pending |
Array
(
[id] => 19014190
[patent_doc_number] => 11921114
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Systems and processes to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) of 2019 (COVID-19)
[patent_app_type] => utility
[patent_app_number] => 17/337022
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3031
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 278
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17337022
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/337022 | Systems and processes to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) of 2019 (COVID-19) | Jun 1, 2021 | Issued |
Array
(
[id] => 17299523
[patent_doc_number] => 20210395362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => CAR-T CELLS WITH HUMANIZED CD19 SCFV WITH MUTATION IN CDR 1 REGION
[patent_app_type] => utility
[patent_app_number] => 17/334417
[patent_app_country] => US
[patent_app_date] => 2021-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17334417
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/334417 | CAR-T cells with humanized CD19 ScFv with mutation in CDR 1 region | May 27, 2021 | Issued |
Array
(
[id] => 17256851
[patent_doc_number] => 20210369836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => SURFACE DISPLAY OF PROTEINS ON RECOMBINANT BACTERIA AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/330563
[patent_app_country] => US
[patent_app_date] => 2021-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17330563
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/330563 | SURFACE DISPLAY OF PROTEINS ON RECOMBINANT BACTERIA AND USES THEREOF | May 25, 2021 | Abandoned |
Array
(
[id] => 19883468
[patent_doc_number] => 12269155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-08
[patent_title] => Multivalent vaccines for rabies virus and coronaviruses
[patent_app_type] => utility
[patent_app_number] => 17/307066
[patent_app_country] => US
[patent_app_date] => 2021-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 19
[patent_no_of_words] => 27496
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17307066
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/307066 | Multivalent vaccines for rabies virus and coronaviruses | May 3, 2021 | Issued |
Array
(
[id] => 20563573
[patent_doc_number] => 12566179
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-03
[patent_title] => Coronavirus assays, diagnostic methods, treatment methods, and compositions related thereto
[patent_app_type] => utility
[patent_app_number] => 17/922670
[patent_app_country] => US
[patent_app_date] => 2021-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 14
[patent_no_of_words] => 9560
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922670
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/922670 | Coronavirus assays, diagnostic methods, treatment methods, and compositions related thereto | May 2, 2021 | Issued |
Array
(
[id] => 17260033
[patent_doc_number] => 20210373018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => LATERAL FLOW DETECTION DEVICE FOR DETECTING A CORONAVIRUS BY IMMUNOASSAY
[patent_app_type] => utility
[patent_app_number] => 17/244129
[patent_app_country] => US
[patent_app_date] => 2021-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17244129
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/244129 | LATERAL FLOW DETECTION DEVICE FOR DETECTING A CORONAVIRUS BY IMMUNOASSAY | Apr 28, 2021 | Abandoned |
Array
(
[id] => 17201384
[patent_doc_number] => 20210341479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => QUANTITATIVE ANTIBODY TEST
[patent_app_type] => utility
[patent_app_number] => 17/243502
[patent_app_country] => US
[patent_app_date] => 2021-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19366
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -128
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17243502
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/243502 | Quantitative antibody test | Apr 27, 2021 | Issued |
Array
(
[id] => 17496522
[patent_doc_number] => 11285206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-29
[patent_title] => Heat-resistant recombinant Newcastle Disease Virus vaccine strain capable of expressing truncated Fiber 2 protein of Fowl Adenovirus serotype 4, preparation method and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/234795
[patent_app_country] => US
[patent_app_date] => 2021-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 2532
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17234795
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/234795 | Heat-resistant recombinant Newcastle Disease Virus vaccine strain capable of expressing truncated Fiber 2 protein of Fowl Adenovirus serotype 4, preparation method and application thereof | Apr 19, 2021 | Issued |
Array
(
[id] => 17227173
[patent_doc_number] => 20210353729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => NOVEL CANCER ANTIGENS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/232597
[patent_app_country] => US
[patent_app_date] => 2021-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30342
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17232597
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/232597 | Cancer antigens and methods | Apr 15, 2021 | Issued |
Array
(
[id] => 17171718
[patent_doc_number] => 20210325388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => LATERAL FLOW DETECTION DEVICE FOR DETECTING A CORONAVIRUS BY IMMUNOASSAY
[patent_app_type] => utility
[patent_app_number] => 17/230302
[patent_app_country] => US
[patent_app_date] => 2021-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17230302
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/230302 | LATERAL FLOW DETECTION DEVICE FOR DETECTING A CORONAVIRUS BY IMMUNOASSAY | Apr 13, 2021 | Abandoned |
Array
(
[id] => 17050749
[patent_doc_number] => 20210260183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => RAPID AND PROLONGED IMMUNOLOGIC-THERAPEUTIC
[patent_app_type] => utility
[patent_app_number] => 17/214885
[patent_app_country] => US
[patent_app_date] => 2021-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26603
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214885
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/214885 | Rapid and prolonged immunologic-therapeutic | Mar 27, 2021 | Issued |
Array
(
[id] => 17120545
[patent_doc_number] => 11131672
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2021-09-28
[patent_title] => Method for detecting MERS-CoV in Camilidae
[patent_app_type] => utility
[patent_app_number] => 17/207063
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11467
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17207063
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/207063 | Method for detecting MERS-CoV in Camilidae | Mar 18, 2021 | Issued |
Array
(
[id] => 18467056
[patent_doc_number] => 20230201336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => INFLUENZA VIRUS-LIKE PARTICLES (VLPS)
[patent_app_type] => utility
[patent_app_number] => 17/996300
[patent_app_country] => US
[patent_app_date] => 2021-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10240
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996300
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996300 | INFLUENZA VIRUS-LIKE PARTICLES (VLPS) | Mar 8, 2021 | Pending |